Results 171 to 180 of about 641,866 (350)
A subset of MMR‐proficient colon cancers responds to neoadjuvant immunotherapy
Tan et al. reveal that a distinct subset of early‐stage pMMR colon cancers can respond to neoadjuvant immunotherapy. In the NICHE‐2 trial, responders (26%) were characterized by chromosomal instability, TP53 mutations, and proliferative cell‐cycle programs, whereas nonresponders showed metabolic and stromal reprogramming with TGF‐β‐driven ...
Eleonora Piumatti +3 more
wiley +1 more source
Evaluating Behavioral Management Practices for Laboratory Nonhuman Primates: An International Survey. [PDF]
Baker KC, Sewell FR, Prescott MJ.
europepmc +1 more source
Interactive hypermedia : a comparative study of the effects of real-time motion videodisc versus still frame and of cognitive style on cetacea animals knowledge test for second grade students [PDF]
Carole Jean Meshot
openalex
The cancer problem is increasing globally with projections up to the year 2050 showing unfavourable outcomes in terms of incidence and cancer‐related deaths. The main challenges are prevention, improved therapeutics resulting in increased cure rates and enhanced health‐related quality of life.
Ulrik Ringborg +43 more
wiley +1 more source
Performance of Large Language Models and Top-Decile Doctors on an Undergraduate Ophthalmology Examination. [PDF]
Akinniranye O, Akinniranye O.
europepmc +1 more source
Cell surface interactome analysis identifies TSPAN4 as a negative regulator of PD‐L1 in melanoma
Using cell surface proximity biotinylation, we identified tetraspanin TSPAN4 within the PD‐L1 interactome of melanoma cells. TSPAN4 negatively regulates PD‐L1 expression and lateral mobility by limiting its interaction with CMTM6 and promoting PD‐L1 degradation.
Guus A. Franken +7 more
wiley +1 more source
Eating behavior patterns in relation to obesity phenotypes and beige adipose tissue content with a focus on young women; a narrative review. [PDF]
Walkiewicz KW +4 more
europepmc +1 more source

